Download PDF
Horm Metab Res 2003; 35(6): 337-342
DOI: 10.1055/s-2003-41353
Review
© Georg Thieme Verlag Stuttgart · New York

Adipocytokines in Anorexia Nervosa: a Review Focusing on Leptin and Adiponectin

S.  M.  Brichard 1 , M.  L.  Delporte 1 , M.  Lambert 2
  • 1 Endocrinology and Metabolism Unit
  • 2 Division of General Internal Medicine, Saint-Luc University Hospital, University of Louvain, Medical School, Brussels, Belgium
Further Information

Publication History

Received 17 December 2002

Accepted after Revision 11 March 2003

Publication Date:
15 August 2003 (online)

Also available at
    Permissions and Reprints

Abstract

Adipose tissue secretes a large number of physiologically active peptides that often share structural properties with cytokines, and are therefore collectively referred to as ”adipocytokines”. Some of these are almost exclusively secreted by adipose tissue. Leptin, adiponectin and resistin are specific fat-derived hormones that affect fuel homeostasis and insulin action, and may also be involved in hematopoiesis and immune functions. Anorexia nervosa is characterized by chronic self-starvation and severe weight loss, mainly at the expense of adipose tissue. Starvation-induced depletion of fat stores is accompanied by alterations of circulating adipocytokines. Plasma leptin and likely resistin levels are decreased in anorectic patients, while plasma adiponectin levels are increased. These alterations may have potential repercussions in the pathophysiology of anorexia nervosa. Thus, low leptin and high adiponectin may separately or in concert contribute to altered hematopoiesis and immunity, enhanced insulin sensitivity, neuroendocrine disturbances or osteopenia in anorexia nervosa.

Key words

Leptin - Resistin - Adiponectin - Starvation - Insulin Action - Fuel Homeostasis

References

  • 1 Lambert M, Lion L, Vanderdonckt J, Maiter D. Anormalies endocriniennes de l'anorexie mentale.  Rev Franç Endocrinol Clin. 1997;  38 569-577
    PubMedGoogle Scholar
  • 2 Stoving R K, Hangaard J, Hansen-Nord M, Hagen C. A review of endocrine changes in anorexia nervosa.  J Psychiatr Res. 1999;  33 139-152
    CrossrefPubMedGoogle Scholar
  • 3 Rubin R T, Kaye W H. Anorexia nervosa and others eating disorders.  In: Endocrinology. DeGroot LJ and Jameson JL (Eds) Philadelphia; W. B. Saunders Company 2001: 631-641
    Google Scholar
  • 4 Lambert M, Hubert C, Depresseux G, Vande B B, Thissen J P, Nagant d D. Hematological changes in anorexia nervosa are correlated with total body fat mass depletion.  Int J Eat Disord. 1997;  21 329-334
    CrossrefPubMedGoogle Scholar
  • 5 Devuyst O, Lambert M, Rodhain J, Lefebvre C, Coche E. Haematological changes and infectious complications in anorexia nervosa: a case-control study.  Q J Med. 1993;  86 791-799
    PubMedGoogle Scholar
  • 6 Grinspoon S, Thomas L, Miller K, Herzog D, Klibanski A. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa.  J Clin Endocrinol Metab. 2002;  87 2883-2891
    Google Scholar
  • 7 Trayhurn P, Beattie J H. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ.  Proc Nutr Soc. 2001;  60 329-339
    CrossrefPubMedGoogle Scholar
  • 8 Ravussin E, Smith S R. Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus.  Ann N Y Acad Sci. 2002;  967 363-378
    PubMedGoogle Scholar
  • 9 Caro J F, Sinha M K, Kolaczynski J W, Zhang P L, Considine R V. Leptin: the tale of an obesity gene.  Diabetes. 1996;  45 1455-1462
    PubMedGoogle Scholar
  • 10 Chan J L, Bluher S, Yiannakouris N, Suchard M A, Kratzsch J, Mantzoros C S. Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans.  Diabetes. 2002;  51 2105-2112
    CrossrefPubMedGoogle Scholar
  • 11 Grinspoon S, Gulick T, Askari H, Landt M, Lee K, Anderson E, Ma Z, Vignati L, Bowsher R, Herzog D, Klibanski A. Serum leptin levels in women with anorexia nervosa.  J Clin Endocrinol Metab. 1996;  81 3861-3863
    PubMedGoogle Scholar
  • 12 Mantzoros C, Flier J S, Lesem M D, Brewerton T D, Jimerson D C. Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain.  J Clin Endocrinol Metab. 1997;  82 1845-1851
    CrossrefPubMedGoogle Scholar
  • 13 Ferron F, Considine R V, Peino R, Lado I G, Dieguez C, Casanueva F F. Serum leptin concentrations in patients with anorexia nervosa, bulimia nervosa and non-specific eating disorders correlate with the body mass index but are independent of the respective disease.  Clin Endocrinol. 1997;  46 289-293
    CrossrefPubMedGoogle Scholar
  • 14 Balligand J L, Brichard S M, Brichard V, Desager J P, Lambert M. Hypoleptinemia in patients with anorexia nervosa: loss of circadian rhythm and unresponsiveness to short-term refeeding.  Eur J Endocrinol. 1998;  138 415-420
    CrossrefPubMedGoogle Scholar
  • 15 Kratzsh J, Lammert A, Bottner A, Seidel B, Mueller G, Thiery J, Hedebrand J, Kiess W. Circulating soluble leptin receptor and free leptin index during childhood, puberty, and adolescence.  J Clin Endocrinol Metab. 2002;  87 4587-4594
    CrossrefPubMedGoogle Scholar
  • 16 Stoving R K, Vinten J, Handberg A, Ebbesen E N, Hangaard J, Hansen-Nord M, Kristiansen J, Hagen C. Diurnal variation of the serum leptin concentration in patients with anorexia nervosa.  Clin Endocrinol. 1998;  48 761-768
    CrossrefPubMedGoogle Scholar
  • 17 Laughlin G A, Yen S S. Hypoleptinemia in women athletes: absence of a diurnal rhythm with amenorrrhea.  J Clin Endocrinol Metab. 1997;  82 318-321
    CrossrefPubMedGoogle Scholar
  • 18 Casanueva F F, Dieguez C, Popovic V, Peino R, Considine R V, Caro J F. Serum immunoreactive leptin concentrations in patients with anorexia nervosa before and after partial weight recovery.  Biochem Mol Med. 1997;  60 116-120
    CrossrefPubMedGoogle Scholar
  • 19 Hebebrand J, Blum W F, Barth N, Coners H, Englaro P, Juul A, Ziegler A, Warnke A, Rascher W, Remschmidt H. Leptin levels in patients with anorexia nervosa are reduced in the acute stage and elevated upon short-term weight restoration.  Mol Psychiatry. 1997;  2 330-334
    CrossrefPubMedGoogle Scholar
  • 20 Ahima R S, Flier J S. Adipose tissue as an endocrine organ.  Trends Endocrinol Metab. 2000;  11 327-332
    PubMedGoogle Scholar
  • 21 Farooqi I S. Leptin and the onset of puberty: insights from rodent and human genetics.  Semin Reprod Med. 2002;  20 139-144
    PubMedGoogle Scholar
  • 22 Ahima R S, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier J S. Role of leptin in the neuroendocrine response to fasting.  Nature. 1996;  382 250-252
    CrossrefPubMedGoogle Scholar
  • 23 Bennett B D, Solar G P, Yuan J Q, Mathias J, Thomas G R, Matthews W. A role for leptin and its cognate receptor in hematopoiesis.  Curr Biol. 1996;  6 1170-1180
    CrossrefPubMedGoogle Scholar
  • 24 Faggioni R, Feingold K R, Grunfeld C. Leptin regulation of the immune response and the immunodeficiency of malnutrition.  FASEB J. 2001;  15 2565-2571
    CrossrefPubMedGoogle Scholar
  • 25 Faggioni R, Moser A, Feingold K R, Grunfeld C. Reduced leptin levels in starvation increase susceptibility to endotoxic shock.  Am J Pathol. 2000;  156 1781-1787
    PubMedGoogle Scholar
  • 26 Vande B erg, Malghem J, Devuyst O, Maldague B E, Lambert M J. Anorexia nervosa: correlation between MR appearance of bone marrow and severity of disease.  Radiology. 1994;  193 859-864
    PubMedGoogle Scholar
  • 27 Vaisman N, Barak Y, Hahn T, Karov Y, Malach L, Barak V. Defective in vitro granulopoiesis in patients with anorexia nervosa.  Pediatr Res. 1996;  40 108-111
    PubMedGoogle Scholar
  • 28 Nova E, Gomez-Martinez S, Morande G, Marcos A. Cytokine production by blood mononuclear cells from in-patients with anorexia nervosa.  Br J Nutr. 2002;  88 183-188
    CrossrefPubMedGoogle Scholar
  • 29 Reseland J, Gordeladze J. Role of leptin in bone growth: central player or peripheral supporter?.  FEBS Lett. 2002;  528 540
    PubMedGoogle Scholar
  • 30 Goldstone A P, Howard J K, Lord G M, Ghatei M A, Gardiner J V, Wang Z L, Wang R M, Girgis S I, Bailey C J, Bloom S R. Leptin prevents the fall in plasma osteocalcin during starvation in male mice.  Biochem Biophys Res Commun. 2002;  295 475-481
    CrossrefPubMedGoogle Scholar
  • 31 Berg A H, Combs T P, Scherer P E. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism.  Trends Endocrinol Metab. 2002;  13 84-89
    CrossrefPubMedGoogle Scholar
  • 32 Tsao T S, Lodish H F, Fruebis J. ACRP30, a new hormone controlling fat and glucose metabolism.  Eur J Pharmacol. 2002;  440 213-221
    CrossrefPubMedGoogle Scholar
  • 33 Stefan N, Stumvoll M. Adiponectin - its role in metabolism and beyond.  Horm Metab Res. 2002;  34 469-474
    Article in Thieme ConnectPubMedGoogle Scholar
  • 34 Fruebis J, Tsao T S, Javorschi S, Ebbets-Reed D, Erickson M R, Yen F T, Bihain B E, Lodish H F. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice.  Proc Natl Acad Sci USA. 2001;  98 2005-2010
    CrossrefPubMedGoogle Scholar
  • 35 Berg A H, Combs T P, Du X, Brownlee M, Scherer P E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action.  Nat Med. 2001;  7 947-953
    CrossrefPubMedGoogle Scholar
  • 36 Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman M L, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.  Nat Med. 2001;  7 941-946
    CrossrefPubMedGoogle Scholar
  • 37 Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn B B, Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.  Nat Med. 2002;  8 1288-1295
    CrossrefPubMedGoogle Scholar
  • 38 Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin.  Circulation. 1999;  100 2473-2476
    CrossrefPubMedGoogle Scholar
  • 39 Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, Yano W, Froguel P, Nagai R, Kimura S, Kadowaki T, Noda T. Disruption of adiponectin causes insulin resistance and neointimal formation.  J Biol Chem. 2002;  277 25 863-25 866
    PubMedGoogle Scholar
  • 40 Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, Kihara S, Funahashi T, Tenner A J, Tomiyama Y, Matsuzawa Y. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the function of macrophages.  Blood. 2000;  96 1723-1732
    PubMedGoogle Scholar
  • 41 Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.  Biochem Biophys Res Commun. 1999;  257 79-83
    CrossrefPubMedGoogle Scholar
  • 42 Haque W A, Shimomura I, Matsuzawa Y, Garg A. Serum adiponectin and leptin levels in patients with lipodystrophies.  J Clin Endocrinol Metab. 2002;  87 2395
    CrossrefPubMedGoogle Scholar
  • 43 Delporte M L, Brichard S M, Hermans M P, Beguin C, Lambert M. Hyperadiponectinaemia in anorexia nervosa.  Clin Endocrinol (Oxf). 2003;  58 22-29
    CrossrefPubMedGoogle Scholar
  • 44 Yang W S, Lee W J, Funahashi T, Tanaka S, Matsuzawa Y, Chao C L, Chen C L, Tai T Y, Chuang L M. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin.  J Clin Endocrinol Metab. 2001;  86 3815-3819
    CrossrefPubMedGoogle Scholar
  • 45 Halleux C M, Takahashi M, Delporte M L, Detry R, Funahashi T, Matsuzawa Y, Brichard S M. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue.  Biochem Biophys Res Commun. 2001;  288 1102-1107
    CrossrefPubMedGoogle Scholar
  • 46 Zuniga-Guajardo S, Garfinkel P E, Zinman B. Changes in insulin sensitivity and clearance in anorexia nervosa.  Metabolism. 1986;  35 1096-1100
    CrossrefPubMedGoogle Scholar
  • 47 Fukushima M, Nakai Y, Taniguchi A, Imura H, Nagata I, Tokuyama K. Insulin sensitivity, insulin secretion, and glucose effectiveness in anorexia nervosa: a minimal model analysis.  Metabolism. 1993;  42 1164-1168
    CrossrefPubMedGoogle Scholar
  • 48 Hermans M P, Lambert M J. HOMA-modelling of insulin sensitivity and beta-cell function in anorexia nervosa.  European Eating Disorders Review. 2002;  10 41-50
    CrossrefPubMedGoogle Scholar
  • 49 Bogan J S, Lodish H F. Two compartments for insulin-stimulated exocytosis in 3T3-L1 adipocytes defined by endogenous ACRP30 and GLUT4.  J Cell Biol. 1999;  146 609-620
    CrossrefPubMedGoogle Scholar
  • 50 Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein.  Diabetes. 2001;  50 2094-2099
    CrossrefPubMedGoogle Scholar
  • 51 Yang W S, Jeng C Y, Wu T J, Tanaka S, Funahashi T, Matsuzawa Y, Wang J P, Chen C L, Tai T Y, Chuang L M. Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients.  Diabetes Care. 2002;  25 376-380
    CrossrefPubMedGoogle Scholar
  • 52 Warren M P. 1995 Anorexia nervosa. In: Endocrinology. DeGroot LJ (Ed) Philadelphia; W. B. Saunders 2679-2691
    Google Scholar
  • 53 Urwin R E, Bennetts B, Wilcken B, Lampropoulos B, Beumont P, Clarke S, Russell J, Tanner S, Nunn K P. Anorexia nervosa (restrictive subtype) is associated with a polymorphism in the novel norepinephrine transporter gene promoter polymorphic region.  Mol Psychiatry. 2002;  7 652-657
    CrossrefPubMedGoogle Scholar
  • 54 Delporte M L, Funahashi T, Takahashi M, Matsuzawa Y, Brichard S M. Pre- and post-translational negative effect of beta-adrenoceptor agonists on adiponectin secretion: in vitro and in vivo studies.  Biochem J. 2002;  367 677-685
    CrossrefPubMedGoogle Scholar
  • 55 Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes.  FEBS Lett. 2001;  507 142-146
    CrossrefPubMedGoogle Scholar
  • 56 Kappes A, Loffler G. Influences of ionomycin, dibutyryl-cycloAMP and tumour necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes.  Horm Metab Res. 2000;  32 548-554
    PubMedGoogle Scholar
  • 57 Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J, Paschke R. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes.  Biochemical and Biophysical Research Communications. 2003;  301 1045-1050
    CrossrefPubMedGoogle Scholar
  • 58 Corcos M, Guilbaud O, Paterniti S, Moussa M, Chambry J, Chaouat G, Consoli S M, Jeammet P. Involvement of cytokines in eating disorders: a critical review of the human literature.  Psychoneuroendocrinology. 2003;  28 229-249
    CrossrefPubMedGoogle Scholar
  • 59 Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, Uchida S, Ito Y, Takakuwa K, Matsui J, Takata M, Eto K, Terauchi Y, Komeda K, Tsunoda M, Murakami K, Ohnishi Y, Naitoh T, Yamamura K, Ueyama Y, Froguel P, Kimura S, Nagai R, Kadowaki T. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis.  J Biol Chem. 2003;  278 2461-2468
    CrossrefPubMedGoogle Scholar
  • 60 Yokota T, Meka C S, Medina K L, Igarashi H, Comp P C, Takahashi M, Nishida M, Oritani K, Miyagawa J, Funahashi T, Tomiyama Y, Matsuzawa Y, Kincade P W. Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins.  J Clin Invest. 2002;  109 1303-1310
    CrossrefPubMedGoogle Scholar
  • 61 Steppan C M, Lazar M A. Resistin and obesity-associated insulin resistance.  Trends Endocrinol Metab. 2002;  13 18-23
    CrossrefPubMedGoogle Scholar
  • 62 Steppan C M, Bailey S T, Bhat S, Brown E J, Banerjee R R, Wright C M, Patel H R, Ahima R S, Lazar M A. The hormone resistin links obesity to diabetes.  Nature. 2001;  409 307-312
    CrossrefPubMedGoogle Scholar
  • 63 Ghosh S, Singh A K, Aruna B, Mukhopadhyay S, Ehtesham N Z. The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications.  Gene. 2003;  305 27-34
    CrossrefPubMedGoogle Scholar
  • 64 Savage D B, Sewter C P, Klenk E S, Segal D G, Vidal-Puig A, Considine R V, O"Rahilly S. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans.  Diabetes. 2001;  50 2199-2202
    CrossrefPubMedGoogle Scholar
  • 65 Nagaev I, Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle.  Biochem Biophys Res Commun. 2001;  285 561-564
    CrossrefPubMedGoogle Scholar
  • 66 Fain J N, Cheema P S, Bahouth S W, Lloyd H M. Resistin release by human adipose tissue explants in primary culture.  Biochem Biophys Res Commun. 2003;  300 674-678
    CrossrefPubMedGoogle Scholar
  • 67 Janke J, Engeli S, Gorzelniak K, Luft F C, Sharma A M. Resistin gene expression in human adipocytes is not related to insulin resistance.  Obes Res. 2002;  10 1-5
    CrossrefPubMedGoogle Scholar
  • 68 McTernan P G, McTernan C L, Chetty R, Jenner K, Fisher F M, Lauer M N, Crocker J, Barnett A H, Kumar S. Increased resistin gene and protein expression in human abdominal adipose tissue.  J Clin Endocrinol Metab. 2002;  87 2407
    CrossrefPubMedGoogle Scholar
  • 69 Morash B A, Willkinson D, Ur E, Wilkinson M. Resistin expression and regulation in mouse pituitary.  FEBS Lett. 2002;  526 26-30
    CrossrefPubMedGoogle Scholar
  • 70 Kim K H, Lee K, Moon Y S, Sul H S. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation.  J Biol Chem. 2001;  276 11 252-11 256
    PubMedGoogle Scholar
  • 71 Nakai Y, Hamagaki S, Takagi R, Taniguchi A, Kurimoto F. Plasma concentrations of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in patients with anorexia nervosa.  J Clin Endocrinol Metab. 1999;  84 1226-1228
    CrossrefPubMedGoogle Scholar
  • 72 Holden R J, Pakula I S. Tumor necrosis factor-alpha: is there a continuum of liability between stress, anxiety states and anorexia nervosa?.  Med Hypotheses. 1999;  52 155-162
    PubMedGoogle Scholar
  • 73 Raymond N C, Dysken M, Bettin K, Eckert E D, Crow S J, Markus K, Pomeroy C. Cytokine production in patients with anorexia nervosa, bulimia nervosa, and obesity.  Int J Eat Disord. 2000;  28 293-302
    CrossrefPubMedGoogle Scholar
  • 74 Brambilla F, Monti D, Franceschi C. Plasma concentrations of interleukin-1-beta, interleukin-6 and tumor necrosis factor-alpha, and of their soluble receptors and receptor antagonist in anorexia nervosa.  Psychiatry Res. 2001;  103 107-114
    CrossrefPubMedGoogle Scholar

S. M. Brichard

Unité d'Endocrinologie et Métabolisme

UCL 5530 Av. Hippocrate, 55 · 1200 Brussels · Belgium ·

Phone: +32-2-7645530

Fax: +32-2-7645532

Email: brichard@endo.ucl.ac.be

      >